神経修復&再生の世界市場2022-2028:産業分析・予測

◆英語タイトル:Global Nerve Repair and Regeneration Market Size, Share & Industry Trends Analysis Report By Surgery, By Product (Neuromodulation Surgery Devices and Biomaterials), By Regional Outlook and Forecast, 2022 - 2028

KBV Researchが発行した調査報告書(KBV22JL092)◆商品コード:KBV22JL092
◆発行会社(リサーチ会社):KBV Research
◆発行日:2022年5月
◆ページ数:167
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、イギリス、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、UAE、サウジアラビア、南アフリカ共和国、ナイジェリア
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,600 ⇒換算¥532,800見積依頼/購入/質問フォーム
Site License(同一拠点内で共有可)USD4,320 ⇒換算¥639,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

KBVリサーチ社では、世界の神経修復&再生市場規模が2028年まで94億ドルに達っし、予測期間中、年平均6.4%成長率で上昇すると予想しています。本調査レポートでは、神経修復&再生の世界市場について幅広く調査し、市場範囲・手法、市場動向、競争分析、手術別(神経調節手術、ニューロパチー、神経移植、幹細胞治療)分析、製品別(神経調節手術装置、生体材料)分析、地域別分析、企業情報などの項目を掲載しています。企業情報としては、Abbott Laboratories、Boston Scientific Corporation、Integra Lifesciences Corporation、Medtronic PLC、Axogen, Inc.、Stryker Corporation、Checkpoint Surgical, Inc.、Polyganics BV、Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)、OrthoMed, Inc.などが含まれています。
・市場範囲・手法
・市場動向
・競争分析
・世界の神経修復&再生市場規模:手術別(神経調節手術、ニューロパチー、神経移植、幹細胞治療)
・世界の神経修復&再生市場規模:製品別(神経調節手術装置、生体材料)
・世界の神経修復&再生市場規模:地域別(北米、ヨーロッパ、アジア太平洋、南米・中東・アフリカ)
・企業情報

The Global Nerve Repair and Regeneration Market size is expected to reach $9.4 billion by 2028, rising at a market growth of 6.4% CAGR during the forecast period.
Neurostimulation, neuromodulators, and biomaterial devices are among the goods available for nerve repair and regeneration. These devices are used to treat traumatic or neurodegenerative conditions such Alzheimer’s, Parkinson’s, multiple sclerosis, amyotrophic lateral sclerosis, and multiple system atrophy. The spinal cord,brain, and peripheral nerves are all delicate and easily damaged, which can make it difficult for the brain to communicate with muscles and organs. These damages are repaired with nerve repair and regeneration products.
As in developing countries, the market opportunity for nerve repair and regeneration is growing, because healthcare spending continues to climb. The overall increase in awareness of the usage of nerve repair and regeneration devices to treat ailments including Parkinson’s disease, Alzheimer’s disease, and other neurological disorders is predicted to boost market growth. Furthermore, the nerve repair and regeneration market is expected to grow as individuals become more aware of therapeutic treatments such as immune response and neuroregeneration, spinal cord repair, peripheral nerve regeneration and repair, and nerve cell regrowth.
Remyelination post grade I lesions and collateral axon sprouting and proximal-to-distal nerve regeneration following grade II to grade V lesions are the two methods of nerve regeneration. Healing of function happens as the Schwann split happens and initiates remyelination in focal demyelinating lesions. Conduction, and hence strength, is restored in a matter of weeks or months, although the new myelin sheath is frequently thinner and has many internodes for each original internode.

COVID-19 Impact
The emergence of COVID-19 had a detrimental influence on the nerve repair and regeneration sector, as hospital and healthcare services were drastically decreased as a result of global social distancing measures. Furthermore, the COVID-19 pandemic had an economic impact and had a significant influence on normal hospital care for non-COVID-19 patients in hospitals all over the world. The need for nerve repair or regeneration procedures has decreased while numerous hospitals and clinics remain closed due to the lockdown.

Market Growth Factors
Rise in number of researches around the world
With the large population bases, rising incidences of neurological illnesses, and growing healthcare infrastructure and expenditure, emerging economies like India, China, and Brazil offer lucrative new opportunities to the companies operating in this market. As various stem cell treatment studies under way for nerve repair and regeneration, the developing technologies of stem cell therapy also provide huge prospects for market expansion. In the last several years, research in the field of neurology has expanded and continues to increase.

Increasing cases of nerve injuries
Nerve repair and regeneration products are in high demand due to the rising frequency of neurological illnesses and the increased number of occurrences of nerve injury. The geriatric population is growing all across the world. The market’s growth is fueled by the large geriatric population and the widespread frequency and incidence of nerve illnesses among them. Market players and researchers are concentrating their efforts on developing neurostimulation and neuromodulation technologies like next-generation neurostimulation devices, company collaborations to launch advanced products, and the introduction of new technologies, are propelling the market forward. The government’s funding in neurological illness research is helping healthcare organizations to boost their research work and improve the efficacy of the nerve repair and regeneration products and procedures.

Market Restraining Factors
Lack of skilled healthcare professionals
The market is confronted with a number of obstacles that are slowing its rate of expansion. There is a shortage of qualified experts who are required for neurological interventions due to a wide disparity between demand and supply of neurologists around the world. Tissue morbidity affects donor nerves frequently, which is a big problem. Neural gaps more than 3 cm are difficult to fix with nerve conduits. Neuromodulation and neurostimulation devices, for example, fall under Class II or Class III medical devices, depending on the application, and require premarket notification via the 510(k) process for clearance and marketing in the US market.

Surgery Outlook
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Stem Cell Therapy segment recorded a substantial revenue share in nerve repair and regeneration market in 2021. The market is expected to increase as a result of various government efforts and approvals to perform clinical studies of biomaterials. In the United States, there are roughly 570 clinics that provide stem cell therapies, and this number is likely to grow, boosting segment growth.

Product Outlook
Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. The neuromodulation surgery devices segment acquired the largest revenue share in nerve repair and regeneration market in 2021. It is because of increased consumer awareness of nerve repair and new technology breakthroughs in the healthcare industry. In addition, the segment’s expansion was fueled by a substantial number of commonly available spinal cord products and a diverse range of applications.

Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as a leading region in the nerve repair and regeneration market in 2021 with the largest revenue share. It is due to an increase in the occurrence of neurodegenerative and neurodevelopmental illnesses, stroke, and traumatic brain injuries, as well as an increase in patient awareness of nerve repair and regeneration techniques.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories are the forerunners in the Nerve Repair and Regeneration Market. Companies such as Medtronic PLC, Boston Scientific Corporation and Stryker Corporation are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market.
Key Companies Profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.

Recent Strategies Deployed in Nerve Repair and Regeneration Market
Product Launches and Product Expansions:
Mar-2022: Integra LifeSciences introduced NeuraGen 3D Nerve Guide Matrix, a resorbable implant for the repair of peripheral nerve discontinuities. This product is developed to make an optimized environment, which would enable a more complete functional recovery following mid-gap nerve repair when compared to hollow nerve conduits alone.
Aug-2021: Checkpoint Surgical expanded its intraoperative nerve care product line with the launch of the NeuroShield Chitosan Nerve Wrap. This product would mark Checkpoint’s first product in a planned line of chitosan-based biological implants to support nerve healing. By adding NeuroShield, Checkpoint would take a significant step toward a more comprehensive intraoperative nerve care solution.
Mar-2021: Abbott unveiled NeuroSphere Virtual Clinic, a first-of-its-kind technology. This technology enables patients to interact with physicians, make sure proper settings and functionality, and get new treatment settings remotely as per the requirements.
Nov-2020: Abbott launched the IonicRF Generator, a new device recently cleared by the U.S. Food and Drug Administration. This device is used to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The product is a radiofrequency ablation device, which utilized heat to target specific nerves and block pain signals from reaching the brain.

Acquisitions and Mergers:
Aug-2021: Checkpoint Surgical took over NeuroShield from Monarch BioImplants, a Swiss company. In this acquisition, the NeuroShield Wrap would mark Checkpoint’s first product in a planned line of chitosan-based biological implants to help in nerve healing. This acquisition would support Checkpoint Surgical’s existing product portfolio, including the company’s flagship Checkpoint Nerve Stimulator/Locator.
Nov-2020: Medtronic took over Medicrea International, a pioneer in the transformation of spinal surgery. Through this acquisition, Medtronic would become the leader in customized implants and AI-driven planning and prediction capabilities laying a foundation for the future of individualized patient care.
Feb-2020: Medtronic completed the acquisition of Digital Surgery, a UK-based firm with a focus on surgical artificial intelligence (AI), data, and analytics. In this acquisition, Digital Surgery would join the Surgical Robotics business, a part of Medtronic’s Minimally Invasive Therapies Group. In addition, the acquisition would also strengthen Medtronic’s portfolio and its robotic-assisted surgery platform.
Jan-2020: Medtronic acquired Stimgenics, a spinal cord stimulation company. Under this acquisition, Stimgenics developed a spinal cord stimulation waveform known as Differential Target Multiplexed Spinal Cord Stimulation. In addition to this, the therapy is delivered via Medtronic’s Intellis platform and is a chronic pain treatment option. DTM therapy would improve the treatment of chronic pain, supported by clinical evidence and preclinical research on a neuronal-glial mechanism of action.

Approvals and Trials:
Apr-2022: Boston Scientific received approval from The US Food and Drug Administration (FDA) for its Vercise Neural Navigator with STIMVIEW XT, the next-generation image-guided programming software for deep brain stimulation (DBS) therapy. STIMVIEW XT enables healthcare professionals to evaluate real-time lead placement and simulation modeling of brain anatomy for Parkinson’s disease or essential tremor patients.
Feb-2022: Medtronic got approval from the U.S. Food and Drug Administration (FDA) for InterStim X, the next generation of the InterStim portfolio’s recharge-free device. This device is the standard of care in advanced therapy options, and the most customized system, to provide sacral neuromodulation (SNM) therapy.
Oct-2020: Medtronic received approval from U.S. Food and Drug Administration (FDA) for the NIM Vital nerve monitoring system. This system allows physicians to identify, confirm, and monitor nerve function to assist in reducing the risk of nerve damage during head and neck surgery.
Jan-2020: Medtronic received approval from the U.S. Food and Drug Administration for its Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator. This approval would help in the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). This new indication provides patients with DPN access to Medtronic’s top spinal cord stimulation (SCS) portfolio of rechargeable and recharge-free platforms.

Geographical Expansions:
Apr-2021: Polyganics expanded its geographical footprints by building a state-of-the-art, purpose-built facility on the Zernike Campus, Groningen. The new building would house Polyganics’ research laboratories, manufacturing and packaging facilities, and its offices. The expansion would make it important to accommodate Polyganics’ expanding workforce and allow the Company to respond to the rising demand for its commercial and pipeline products.

Scope of the Study
Market Segments covered in the Report:

By Surgery
• Neuromodulation Surgery
• Direct Neuropathy
• Nerve Grafting
• Stem Cell Therapy

By Product
• Neuromodulation Surgery Devices
• Biomaterials

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Abbott Laboratories
• Boston Scientific Corporation
• Integra Lifesciences Corporation
• Medtronic PLC
• Axogen, Inc.
• Stryker Corporation
• Checkpoint Surgical, Inc.
• Polyganics BV
• Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
• OrthoMed, Inc.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

❖ レポートの目次 ❖

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Nerve Repair and Regeneration Market, by Surgery
1.4.2 Global Nerve Repair and Regeneration Market, by Product
1.4.3 Global Nerve Repair and Regeneration Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Global Nerve Repair and Regeneration Market by Surgery
4.1 Global Neuromodulation Surgery Market by Region
4.2 Global Direct Neuropathy Market by Region
4.3 Global Nerve Grafting Market by Region
4.4 Global Stem Cell Therapy Market by Region
Chapter 5. Global Nerve Repair and Regeneration Market by Product
5.1 Global Neuromodulation Surgery Devices Market by Region
5.2 Global Biomaterials Market by Region
Chapter 6. Global Nerve Repair and Regeneration Market by Region
6.1 North America Nerve Repair and Regeneration Market
6.1.1 North America Nerve Repair and Regeneration Market by Surgery
6.1.1.1 North America Neuromodulation Surgery Market by Country
6.1.1.2 North America Direct Neuropathy Market by Country
6.1.1.3 North America Nerve Grafting Market by Country
6.1.1.4 North America Stem Cell Therapy Market by Country
6.1.2 North America Nerve Repair and Regeneration Market by Product
6.1.2.1 North America Neuromodulation Surgery Devices Market by Country
6.1.2.2 North America Biomaterials Market by Country
6.1.3 North America Nerve Repair and Regeneration Market by Country
6.1.3.1 US Nerve Repair and Regeneration Market
6.1.3.1.1 US Nerve Repair and Regeneration Market by Surgery
6.1.3.1.2 US Nerve Repair and Regeneration Market by Product
6.1.3.2 Canada Nerve Repair and Regeneration Market
6.1.3.2.1 Canada Nerve Repair and Regeneration Market by Surgery
6.1.3.2.2 Canada Nerve Repair and Regeneration Market by Product
6.1.3.3 Mexico Nerve Repair and Regeneration Market
6.1.3.3.1 Mexico Nerve Repair and Regeneration Market by Surgery
6.1.3.3.2 Mexico Nerve Repair and Regeneration Market by Product
6.1.3.4 Rest of North America Nerve Repair and Regeneration Market
6.1.3.4.1 Rest of North America Nerve Repair and Regeneration Market by Surgery
6.1.3.4.2 Rest of North America Nerve Repair and Regeneration Market by Product
6.2 Europe Nerve Repair and Regeneration Market
6.2.1 Europe Nerve Repair and Regeneration Market by Surgery
6.2.1.1 Europe Neuromodulation Surgery Market by Country
6.2.1.2 Europe Direct Neuropathy Market by Country
6.2.1.3 Europe Nerve Grafting Market by Country
6.2.1.4 Europe Stem Cell Therapy Market by Country
6.2.2 Europe Nerve Repair and Regeneration Market by Product
6.2.2.1 Europe Neuromodulation Surgery Devices Market by Country
6.2.2.2 Europe Biomaterials Market by Country
6.2.3 Europe Nerve Repair and Regeneration Market by Country
6.2.3.1 Germany Nerve Repair and Regeneration Market
6.2.3.1.1 Germany Nerve Repair and Regeneration Market by Surgery
6.2.3.1.2 Germany Nerve Repair and Regeneration Market by Product
6.2.3.2 UK Nerve Repair and Regeneration Market
6.2.3.2.1 UK Nerve Repair and Regeneration Market by Surgery
6.2.3.2.2 UK Nerve Repair and Regeneration Market by Product
6.2.3.3 France Nerve Repair and Regeneration Market
6.2.3.3.1 France Nerve Repair and Regeneration Market by Surgery
6.2.3.3.2 France Nerve Repair and Regeneration Market by Product
6.2.3.4 Russia Nerve Repair and Regeneration Market
6.2.3.4.1 Russia Nerve Repair and Regeneration Market by Surgery
6.2.3.4.2 Russia Nerve Repair and Regeneration Market by Product
6.2.3.5 Spain Nerve Repair and Regeneration Market
6.2.3.5.1 Spain Nerve Repair and Regeneration Market by Surgery
6.2.3.5.2 Spain Nerve Repair and Regeneration Market by Product
6.2.3.6 Italy Nerve Repair and Regeneration Market
6.2.3.6.1 Italy Nerve Repair and Regeneration Market by Surgery
6.2.3.6.2 Italy Nerve Repair and Regeneration Market by Product
6.2.3.7 Rest of Europe Nerve Repair and Regeneration Market
6.2.3.7.1 Rest of Europe Nerve Repair and Regeneration Market by Surgery
6.2.3.7.2 Rest of Europe Nerve Repair and Regeneration Market by Product
6.3 Asia Pacific Nerve Repair and Regeneration Market
6.3.1 Asia Pacific Nerve Repair and Regeneration Market by Surgery
6.3.1.1 Asia Pacific Neuromodulation Surgery Market by Country
6.3.1.2 Asia Pacific Direct Neuropathy Market by Country
6.3.1.3 Asia Pacific Nerve Grafting Market by Country
6.3.1.4 Asia Pacific Stem Cell Therapy Market by Country
6.3.2 Asia Pacific Nerve Repair and Regeneration Market by Product
6.3.2.1 Asia Pacific Neuromodulation Surgery Devices Market by Country
6.3.2.2 Asia Pacific Biomaterials Market by Country
6.3.3 Asia Pacific Nerve Repair and Regeneration Market by Country
6.3.3.1 China Nerve Repair and Regeneration Market
6.3.3.1.1 China Nerve Repair and Regeneration Market by Surgery
6.3.3.1.2 China Nerve Repair and Regeneration Market by Product
6.3.3.2 Japan Nerve Repair and Regeneration Market
6.3.3.2.1 Japan Nerve Repair and Regeneration Market by Surgery
6.3.3.2.2 Japan Nerve Repair and Regeneration Market by Product
6.3.3.3 India Nerve Repair and Regeneration Market
6.3.3.3.1 India Nerve Repair and Regeneration Market by Surgery
6.3.3.3.2 India Nerve Repair and Regeneration Market by Product
6.3.3.4 South Korea Nerve Repair and Regeneration Market
6.3.3.4.1 South Korea Nerve Repair and Regeneration Market by Surgery
6.3.3.4.2 South Korea Nerve Repair and Regeneration Market by Product
6.3.3.5 Singapore Nerve Repair and Regeneration Market
6.3.3.5.1 Singapore Nerve Repair and Regeneration Market by Surgery
6.3.3.5.2 Singapore Nerve Repair and Regeneration Market by Product
6.3.3.6 Malaysia Nerve Repair and Regeneration Market
6.3.3.6.1 Malaysia Nerve Repair and Regeneration Market by Surgery
6.3.3.6.2 Malaysia Nerve Repair and Regeneration Market by Product
6.3.3.7 Rest of Asia Pacific Nerve Repair and Regeneration Market
6.3.3.7.1 Rest of Asia Pacific Nerve Repair and Regeneration Market by Surgery
6.3.3.7.2 Rest of Asia Pacific Nerve Repair and Regeneration Market by Product
6.4 LAMEA Nerve Repair and Regeneration Market
6.4.1 LAMEA Nerve Repair and Regeneration Market by Surgery
6.4.1.1 LAMEA Neuromodulation Surgery Market by Country
6.4.1.2 LAMEA Direct Neuropathy Market by Country
6.4.1.3 LAMEA Nerve Grafting Market by Country
6.4.1.4 LAMEA Stem Cell Therapy Market by Country
6.4.2 LAMEA Nerve Repair and Regeneration Market by Product
6.4.2.1 LAMEA Neuromodulation Surgery Devices Market by Country
6.4.2.2 LAMEA Biomaterials Market by Country
6.4.3 LAMEA Nerve Repair and Regeneration Market by Country
6.4.3.1 Brazil Nerve Repair and Regeneration Market
6.4.3.1.1 Brazil Nerve Repair and Regeneration Market by Surgery
6.4.3.1.2 Brazil Nerve Repair and Regeneration Market by Product
6.4.3.2 Argentina Nerve Repair and Regeneration Market
6.4.3.2.1 Argentina Nerve Repair and Regeneration Market by Surgery
6.4.3.2.2 Argentina Nerve Repair and Regeneration Market by Product
6.4.3.3 UAE Nerve Repair and Regeneration Market
6.4.3.3.1 UAE Nerve Repair and Regeneration Market by Surgery
6.4.3.3.2 UAE Nerve Repair and Regeneration Market by Product
6.4.3.4 Saudi Arabia Nerve Repair and Regeneration Market
6.4.3.4.1 Saudi Arabia Nerve Repair and Regeneration Market by Surgery
6.4.3.4.2 Saudi Arabia Nerve Repair and Regeneration Market by Product
6.4.3.5 South Africa Nerve Repair and Regeneration Market
6.4.3.5.1 South Africa Nerve Repair and Regeneration Market by Surgery
6.4.3.5.2 South Africa Nerve Repair and Regeneration Market by Product
6.4.3.6 Nigeria Nerve Repair and Regeneration Market
6.4.3.6.1 Nigeria Nerve Repair and Regeneration Market by Surgery
6.4.3.6.2 Nigeria Nerve Repair and Regeneration Market by Product
6.4.3.7 Rest of LAMEA Nerve Repair and Regeneration Market
6.4.3.7.1 Rest of LAMEA Nerve Repair and Regeneration Market by Surgery
6.4.3.7.2 Rest of LAMEA Nerve Repair and Regeneration Market by Product
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Approvals and Trials:
7.3 Boston Scientific Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.5.2 Approvals and Trials:
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisitions and Mergers:
7.6 Axogen, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expenses
7.6.4 Recent strategies and developments:
7.6.4.1 Approvals and Trials:
7.7 Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 OrthoMed, Inc.
7.8.1 Company Overview
7.9 Polyganics BV
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Geographical Expansions:
7.10. Checkpoint Surgical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Acquisition and Mergers:
7.10.2.3 Approvals and Trials:



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経修復&再生の世界市場2022-2028:産業分析・予測(Global Nerve Repair and Regeneration Market Size, Share & Industry Trends Analysis Report By Surgery, By Product (Neuromodulation Surgery Devices and Biomaterials), By Regional Outlook and Forecast, 2022 - 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆